GGiantBullStocks

Zoetis Inc. Class A (ZTS)

NYSE · Healthcare

$76.20-0.47%

As of Jul 20, 2026

Price history

Key statistics

Market cap
$31.36B
P/E ratio
EPS
Volume
4,733,432
52-week high
52-week low
Open
$75.69
Day high
$76.50
Day low
$74.65

Financial highlights

Fiscal yearRevenueNet incomeEPS
2025$9.47B$2.67B$6.02
2024$9.26B$2.49B$5.47
2023$8.54B$2.34B$5.07
2022$8.08B$2.11B$4.49
2021$7.78B$2.04B$4.27

About Zoetis Inc. Class A

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

CEO
Kristin C. Peck
Employees
13,800
Country
US
IPO date
Feb 1, 2013

Similar stocks

Other Healthcare companies

Frequently asked questions

What is Zoetis Inc. Class A's stock price today?
ZTS is trading at $76.20 as of Jul 20, 2026.
What is Zoetis Inc. Class A's market cap?
Zoetis Inc. Class A (ZTS) has a market capitalization of $31.36B.
Does Zoetis Inc. Class A pay a dividend?
Yes. In FY2025, Zoetis Inc. Class A paid $2.03 per share in dividends.
What sector is Zoetis Inc. Class A in?
Zoetis Inc. Class A operates in the Healthcare sector.